{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:55:00Z","timestamp":1777416900450,"version":"3.51.4"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Abiogen Pharma SpA","award":["no number"],"award-info":[{"award-number":["no number"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12020-017-1369-3","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T07:37:10Z","timestamp":1500449830000},"page":"242-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion"],"prefix":"10.1007","volume":"59","author":[{"given":"Sandro","family":"Giannini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"1369_CR1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.mayocp.2013.05.011","volume":"88","author":"A Hossein-nezhad","year":"2013","unstructured":"A. Hossein-nezhad, M.F. Holick, Vitamin D for health: a global perspective. Mayo Clin. Proc. 88, 720\u2013755 (2013)","journal-title":"Mayo Clin. Proc."},{"key":"1369_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1741-7015-11-187","volume":"11","author":"X Deng","year":"2013","unstructured":"X. Deng, Y. Song, J.E. Manson, L.B. Signorello, S.M. Zhang, M.J. Shrubsole, R.M. Ness, D.L. Seidner, Q. Dai, Magnesium, vitamin D status and mortality: results from US national health and nutrition examination survey (NHANES) 2001 to 2006 and NHANES III. BMC Med. 11, 187 (2013)","journal-title":"BMC Med."},{"key":"1369_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5301\/jn.5000027","volume":"25","author":"A Gorini","year":"2012","unstructured":"A. Gorini, A.M. Costanzo, C.G. Egan, U. di Luzio, Paparatti, renal status in adult volunteers in central italy: results from family abbott renal disease monitoring project (FARM) study. J. Nephrol. 25, 523\u2013532 (2012)","journal-title":"J. Nephrol."},{"key":"1369_CR4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/jnci\/djm204","volume":"99","author":"DM Freedman","year":"2007","unstructured":"D.M. Freedman, A.C. Looker, S.-C. Chang, B.I. Graubard, Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst. 99, 1594\u20131602 (2007)","journal-title":"J. Natl. Cancer Inst."},{"key":"1369_CR5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11906-012-0262-y","volume":"14","author":"SR Motiwala","year":"2012","unstructured":"S.R. Motiwala, T.J. Wang, Vitamin D and cardiovascular risk. Curr. Hypertens. Rep. 14, 209\u2013218 (2012)","journal-title":"Curr. Hypertens. Rep."},{"key":"1369_CR6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","volume":"24","author":"EA Gonz\u00e1lez","year":"2004","unstructured":"E.A. Gonz\u00e1lez, A. Sachdeva, D.A. Oliver, K.J. Martin, Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am. J. Nephrol. 24, 503\u2013510 (2004)","journal-title":"Am. J. Nephrol."},{"key":"1369_CR7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.semnephrol.2014.10.002","volume":"34","author":"DJA Goldsmith","year":"2014","unstructured":"D.J.A. Goldsmith, Z.A. Massy, V. Brandenburg, The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD). Semin. Nephrol. 34, 660\u2013668 (2014)","journal-title":"Semin. Nephrol."},{"key":"1369_CR8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357, 266\u2013281 (2007)","journal-title":"N. Engl. J. Med."},{"key":"1369_CR9","first-page":"1397","volume":"36","author":"R Krause","year":"2016","unstructured":"R. Krause, H.J. Roth, H. Kaase, R. Stange, M.F. Holick, Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation. Anticancer Res. 36, 1397\u20131401 (2016)","journal-title":"Anticancer Res."},{"key":"1369_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000355010","volume":"124","author":"MJ Ala-Houhala","year":"2013","unstructured":"M.J. Ala-Houhala, K. V\u00e4h\u00e4vihu, E. Snellman, T. Hasan, H. Kautiainen, P. Karisola, Y. Dombrowski, J. Schauber, H. Saha et al., A narrow-band ultraviolet B course improves vitamin D balance and alters cutaneous CYP27A1 and CYP27B1 mRNA expression levels in hemodialysis patients supplemented with oral vitamin D. Nephron Clin. Pract. 124, 17\u201322 (2013)","journal-title":"Nephron Clin. Pract."},{"key":"1369_CR11","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/ndt\/gfs108","volume":"27","author":"M Cozzolino","year":"2012","unstructured":"M. Cozzolino, D. Brancaccio, G. Cannella, P. Messa, L. Gesualdo, M. Marangella, C. LoDeserto, M. Pozzato, G. Rombol\u00e0 et al., VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH \u2264 150 pg\/mL: results of the Italian FARO Survey. Nephrol. Dial. Transplant. 27, 3588\u20133594 (2012)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MAJ.0b013e31803bb129","volume":"333","author":"S Khan","year":"2007","unstructured":"S. Khan, Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease. Am. J. Med. Sci. 333, 201\u2013207 (2007)","journal-title":"Am. J. Med. Sci."},{"key":"1369_CR13","first-page":"898125","volume":"2013","author":"YH Lai","year":"2013","unstructured":"Y.-H. Lai, T.-C. Fang, The pleiotropic effect of vitamin d. ISRN Nephrol. 2013, 898125 (2013)","journal-title":"ISRN Nephrol."},{"key":"1369_CR14","first-page":"222","volume":"12","author":"C Cipriani","year":"2015","unstructured":"C. Cipriani, S. Piemonte, M. Cilli, J. Pepe, S. Minisola, Update on vitamin D: pros and cons. Clin. Cases Miner. Bone Metab. 12, 222\u2013223 (2015)","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"1369_CR15","doi-asserted-by":"crossref","unstructured":"C.S. Stokes, F. Lammert, Vitamin D supplementation: less controversy, more guidance needed. F1000Res. 5 (2016).","DOI":"10.12688\/f1000research.8863.1"},{"key":"1369_CR16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2010.543","volume":"79","author":"AS Dusso","year":"2011","unstructured":"A.S. Dusso, M. Tokumoto, Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int. 79, 715\u2013729 (2011)","journal-title":"Kidney Int."},{"key":"1369_CR17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/15701611113119990024","volume":"12","author":"S Mazzaferro","year":"2014","unstructured":"S. Mazzaferro, D. Goldsmith, T.E. Larsson, Z.A. Massy, M. Cozzolino, Vitamin D metabolites and\/or analogs: which D for which patient? Curr. Vasc. Pharmacol. 12, 339\u2013349 (2014)","journal-title":"Curr. Vasc. Pharmacol."},{"key":"1369_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"JA Kellum","year":"2012","unstructured":"J.A. Kellum, N. Lameire, P. Aspelin, R.S. Barsoum, E.A. Burdmann, S.L. Goldstein, C.A. Herzog, M. Joannidis, A. Kribben et al., Work group membership. Kidney Int. 2, 1 (2012)","journal-title":"Kidney Int."},{"key":"1369_CR19","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation, K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis. 42, S1\u2013S201 (2003)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR20","unstructured":"KDIGO 2016, (Mineral & bone disorder | KDIGO, 2016), http:\/\/kdigo.org\/home\/mineral-bone-disorder\/"},{"key":"1369_CR21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40620-016-0305-6","volume":"29","author":"LF Morrone","year":"2016","unstructured":"L.F. Morrone, P. Bolasco, C. Camerini, G. Cianciolo, A. Cupisti, A. Galassi, S. Mazzaferro, D. Russo, L. Russo et al., Vitamin D in patients with chronic kidney disease: a position statement of the Working Group \u201cTrace Elements and Mineral Metabolism\u201d of the Italian Society of Nephrology. J. Nephrol. 29, 305\u2013328 (2016)","journal-title":"J. Nephrol."},{"key":"1369_CR22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5455\/msm.2015.27.122-124","volume":"27","author":"D Pavlovic","year":"2015","unstructured":"D. Pavlovic, D. Katicic, T. Gulin, J. Josipovic, Vitamin d in the patients with chronic kidney disease: when, to whom and in which form. Mater Socio-Medica 27, 122\u2013124 (2015)","journal-title":"Mater Socio-Medica"},{"key":"1369_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/kisup.2011.25","volume":"1","author":"M Cozzolino","year":"2011","unstructured":"M. Cozzolino, J. Bover, M. Vervloet, V.M. Brandenburg, A multidisciplinary review of the science of vitamin D receptor activation. Kidney Int. Suppl. 1, 107\u2013110 (2011)","journal-title":"Kidney Int. Suppl."},{"key":"1369_CR24","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/EJE-13-0435","volume":"169","author":"E Romagnoli","year":"2013","unstructured":"E. Romagnoli, J. Pepe, S. Piemonte, C. Cipriani, S. Minisola, Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur. J. Endocrinol. 169, R59\u2013R69 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1369_CR25","doi-asserted-by":"crossref","first-page":"E886","DOI":"10.1210\/jc.2012-3369","volume":"98","author":"SA Shapses","year":"2013","unstructured":"S.A. Shapses, E.J. Lee, D. Sukumar, R. Durazo-Arvizu, S.H. Schneider, The effect of obesity on the relationship between serum parathyroid hormone and 25-hydroxyvitamin D in women. J. Clin. Endocrinol. Metab. 98, E886\u2013890 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00198-004-1757-4","volume":"16","author":"J Pepe","year":"2005","unstructured":"J. Pepe, E. Romagnoli, I. Nofroni, M.T. Pacitti, S. De Geronimo, C. Letizia, G. Tonnarini, A. Scarpiello, E. D\u2019Erasmo et al., Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjectsOsteoporos. Int. J. 16,805\u2013812 (2005)","journal-title":"Osteoporos. Int. J."},{"key":"1369_CR27","first-page":"241","volume":"3","author":"JC Souberbielle","year":"2016","unstructured":"J.-C.Souberbielle, F.Brazier, M.-L.Piketty, C.Cormier, S.Minisola, E.Cavalier, How the reference values for serum parathyroid hormone concentration are (or should be) established? J. Endocrinol. Invest. 3, 241\u2013256 (2016)","journal-title":"J. Endocrinol. Invest."},{"key":"1369_CR28","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1210\/jc.2013-1586","volume":"98","author":"C Cipriani","year":"2013","unstructured":"C. Cipriani, E. Romagnoli, J. Pepe, S. Russo, L. Carlucci, S. Piemonte, L. Nieddu, D.J. McMahon, R. Singh et al., Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J. Clin. Endocrinol. Metab. 98, 2709\u20132715 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.2010.113","volume":"78","author":"A Gal-Moscovici","year":"2010","unstructured":"A. Gal-Moscovici, S.M. Sprague, Use of vitamin D in chronic kidney disease patients. Kidney Int. 78, 146\u2013151 (2010)","journal-title":"Kidney Int."},{"key":"1369_CR30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.kint.2016.04.024","volume":"90","author":"NA Dhayat","year":"2016","unstructured":"N.A. Dhayat, D. Ackermann, M. Pruijm, B. Ponte, G. Ehret, I. Guessous, A.B. Leichtle, F. Paccaud, M. Mohaupt et al., Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int. 90, 648\u2013657 (2016)","journal-title":"Kidney Int."},{"key":"1369_CR31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ki.2013.537","volume":"86","author":"MW Taal","year":"2014","unstructured":"M.W. Taal, V. Thurston, N.J. McIntyre, R.J. Fluck, C.W. McIntyre, The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease. Kidney Int. 86, 407\u2013413 (2014)","journal-title":"Kidney Int."},{"key":"1369_CR32","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2012-2276","volume":"97","author":"A Valcour","year":"2012","unstructured":"A. Valcour, F. Blocki, D.M. Hawkins, S.D. Rao, Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J. Clin. Endocrinol. Metab. 97, 3989\u20133995 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03345365","volume":"28","author":"R Vieth","year":"2005","unstructured":"R. Vieth, G.El-Hajj Fuleihan, There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase. J. Endocrinol. Invest. 28, 183\u2013186 (2005)","journal-title":"J. Endocrinol. Invest."},{"key":"1369_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF03345364","volume":"28","author":"RP Heaney","year":"2005","unstructured":"R.P. Heaney, Serum 25-hydroxyvitamin D and parathyroid hormone exhibit threshold behavior. J. Endocrinol. Invest. 28, 180\u2013182 (2005)","journal-title":"J. Endocrinol. Invest."},{"key":"1369_CR35","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3561\u20133569 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR36","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1210\/jc.2014-1415","volume":"99","author":"SJ Silverberg","year":"2014","unstructured":"S.J. Silverberg, B.L. Clarke, M. Peacock, F. Bandeira, S. Boutroy, N.E. Cusano, D. Dempster, E.M. Lewiecki, J.-M. Liu et al., Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3580\u20133594 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR37","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1210\/jc.2013-3349","volume":"99","author":"M Touvier","year":"2014","unstructured":"M. Touvier, M. Deschasaux, M. Montourcy, A. Sutton, N. Charnaux, E. Kesse-Guyot, L.K. Fezeu, P. Latino-Martel, N. Druesne-Pecollo et al., Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J. Clin. Endocrinol. Metab. 99, 1196\u20131203 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR38","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"R. Eastell, M.L. Brandi, A.G. Costa, P. D\u2019Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J. Clin. Endocrinol. Metab. 99, 3570\u20133579 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/EJE-15-0595","volume":"174","author":"JC Souberbielle","year":"2016","unstructured":"J.-C. Souberbielle, C. Massart, S. Brailly-Tabard, C. Cormier, E. Cavalier, P. Delanaye, P. Chanson, Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients. Eur. J. Endocrinol. 174, 315\u2013323 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"1369_CR40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0002-9343(99)80244-7","volume":"99","author":"NH Bell","year":"1995","unstructured":"N.H. Bell, 25-Hydroxyvitamin D3 reverses alteration of the vitamin D-endocrine system in blacks. Am. J. Med. 99, 597\u2013599 (1995)","journal-title":"Am. J. Med."},{"key":"1369_CR41","doi-asserted-by":"crossref","first-page":"841248","DOI":"10.1155\/2014\/841248","volume":"2014","author":"C Cipriani","year":"2014","unstructured":"C. Cipriani, J. Pepe, S. Piemonte, L. Colangelo, M. Cilli, S. Minisola, Vitamin d and its relationship with obesity and muscle. Int. J. Endocrinol. 2014, 841248 (2014)","journal-title":"Int. J. Endocrinol."},{"key":"1369_CR42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0169-6009(08)80095-5","volume":"23","author":"S Minisola","year":"1993","unstructured":"S. Minisola, M.T. Pacitti, A. Scarda, R. Rosso, E. Romagnoli, V. Carnevale, L. Scarnecchia, G.F. Mazzuoli, Serum ionized calcium, parathyroid hormone and related variables: effect of age and sex. Bone Miner. 23, 183\u2013193 (1993)","journal-title":"Bone Miner."},{"key":"1369_CR43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","volume":"75","author":"P Ravani","year":"2009","unstructured":"P. Ravani, F. Malberti, G. Tripepi, P. Pecchini, S. Cutrupi, P. Pizzini, F. Mallamaci, C. Zoccali, Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 75, 88\u201395 (2009)","journal-title":"Kidney Int."},{"key":"1369_CR44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2011.03.020","volume":"58","author":"S Pilz","year":"2011","unstructured":"S. Pilz, S. Iodice, A. Zittermann, W.B. Grant, S. Gandini, Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58, 374\u2013382 (2011)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfq606","volume":"26","author":"C Drechsler","year":"2011","unstructured":"C. Drechsler, M. Verduijn, S. Pilz, F.W. Dekker, R.T. Krediet, E. Ritz, C. Wanner, E.W. Boeschoten, V. Brandenburg et al., Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol. Dial. Transplant. 26, 1024\u20131032 (2011)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5527\/wjn.v5.i5.471","volume":"5","author":"P Molina","year":"2016","unstructured":"P. Molina, J.L. G\u00f3rriz, M.D. Molina, S. Beltr\u00e1n, B. Vizca\u00edno, V. Escudero, J. Kanter, A.I. \u00c1vila, J. Bover et al., What is the optimal level of vitamin D in non-dialysis chronic kidney disease population? World J. Nephrol. 5, 471\u2013481 (2016)","journal-title":"World J. Nephrol."},{"key":"1369_CR47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","volume":"6","author":"P Kandula","year":"2011","unstructured":"P. Kandula, M. Dobre, J.D. Schold, M.J. Schreiber, R. Mehrotra, S.D. Navaneethan, Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin. J. Am. Soc. Nephrol. 6, 50\u201362 (2011)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1369_CR48","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"S. Moe, T. Dr\u00fceke, J. Cunningham, W. Goodman, K. Martin, K. Olgaard, S. Ott, S. Sprague, N. Lameire et al., Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 69, 1945\u20131953 (2006)","journal-title":"Kidney Int."},{"key":"1369_CR49","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","volume":"27","author":"P Marckmann","year":"2012","unstructured":"P. Marckmann, H. Agerskov, S. Thineshkumar, E.-M. Bladbjerg, J.J. Sidelmann, J. Jespersen, M. Nybo, L.M. Rasmussen, D. Hansen et al., Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol. Dial. Transplant. 27, 3523\u20133531 (2012)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/ajcn.112.040642","volume":"96","author":"JA Alvarez","year":"2012","unstructured":"J.A. Alvarez, J. Law, K.E. Coakley, S.M. Zughaier, L. Hao, K. Shahid Salles, H. Wasse, O.M. Guti\u00e9rrez, T.R. Ziegler et al., High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 96, 672\u2013679 (2012)","journal-title":"Am. J. Clin. Nutr."},{"key":"1369_CR51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.06510909","volume":"5","author":"PJ Matias","year":"2010","unstructured":"P.J. Matias, C. Jorge, C. Ferreira, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, A. Ferreira, Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin. J. Am. Soc. Nephrol. 5, 905\u2013911 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1369_CR52","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.2007090970","volume":"19","author":"P Ruggenenti","year":"2008","unstructured":"P. Ruggenenti, E. Perticucci, P. Cravedi, V. Gambara, M. Costantini, S.K. Sharma, A. Perna, G. Remuzzi, Role of remission clinics in the longitudinal treatment of CKD. J. Am. Soc. Nephrol. 19, 1213\u20131224 (2008)","journal-title":"J. Am. Soc. Nephrol."},{"key":"1369_CR53","doi-asserted-by":"crossref","first-page":"e0140138","DOI":"10.1371\/journal.pone.0140138","volume":"10","author":"S Borrelli","year":"2015","unstructured":"S. Borrelli, D. Leonardis, R. Minutolo, P. Chiodini, L. De Nicola, C. Esposito, F. Mallamaci, C. Zoccali, G. Conte, Epidemiology of CKD regression in patients under nephrology care. PLoS One 10, e0140138 (2015)","journal-title":"PLoS One"},{"key":"1369_CR54","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2215\/CJN.01180211","volume":"6","author":"L Nicola De","year":"2011","unstructured":"L. De Nicola, P. Chiodini, C. Zoccali, S. Borrelli, B. Cianciaruso, B. Di Iorio, D. Santoro, V. Giancaspro, C. Abaterusso et al., Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clin. J. Am. Soc. Nephrol. 6, 2421\u20132428 (2011)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1369_CR55","doi-asserted-by":"crossref","first-page":"e0127071","DOI":"10.1371\/journal.pone.0127071","volume":"10","author":"L Nicola De","year":"2015","unstructured":"L. De Nicola, M. Provenzano, P. Chiodini, S. Borrelli, C. Garofalo, M. Pacilio, M.E. Liberti, A. Sagliocca, G. Conte et al., Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care. PLoS One 10, e0127071 (2015)","journal-title":"PLoS One"},{"key":"1369_CR56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.2009.175","volume":"78","author":"YC Li","year":"2010","unstructured":"Y.C. Li, Renoprotective effects of vitamin D analogs. Kidney Int. 78, 134\u2013139 (2010)","journal-title":"Kidney Int."},{"key":"1369_CR57","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ki.2010.77","volume":"77","author":"R Agarwal","year":"2010","unstructured":"R. Agarwal, Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects? Kidney Int. 77, 943\u2013945 (2010)","journal-title":"Kidney Int."},{"key":"1369_CR58","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","volume":"68","author":"R Agarwal","year":"2005","unstructured":"R. Agarwal, M. Acharya, J. Tian, R.L. Hippensteel, J.Z. Melnick, P. Qiu, L. Williams, D. Batlle, Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 68, 2823\u20132828 (2005)","journal-title":"Kidney Int."},{"key":"1369_CR59","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","volume":"376","author":"D Zeeuw de","year":"2010","unstructured":"D. de Zeeuw, R. Agarwal, M. Amdahl, P. Audhya, D. Coyne, T. Garimella, H.-H. Parving, Y. Pritchett, G. Remuzzi et al., Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomized controlled trial. Lancet 376, 1543\u20131551 (2010)","journal-title":"Lancet"},{"key":"1369_CR60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2011.09.014","volume":"59","author":"LJ Liu","year":"2012","unstructured":"L.-J. Liu, J.-C. Lv, S.-F. Shi, Y.-Q. Chen, H. Zhang, H.-Y. Wang, Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial. Am. J. Kidney Dis. 59, 67\u201374 (2012)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2369-13-150","volume":"13","author":"L Nicola De","year":"2012","unstructured":"L. De Nicola, G. Conte, D. Russo, A. Gorini, R. Minutolo, Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study. BMC Nephrol. 13, 150 (2012)","journal-title":"BMC Nephrol."},{"key":"1369_CR62","doi-asserted-by":"crossref","first-page":"e0118174","DOI":"10.1371\/journal.pone.0118174","volume":"10","author":"E Riccio","year":"2015","unstructured":"E. Riccio, M. Sabbatini, D. Bruzzese, I. Capuano, S. Migliaccio, M. Andreucci, A. Pisani, Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. PLoS One 10, e0118174 (2015)","journal-title":"PLoS One"},{"key":"1369_CR63","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2011.224","volume":"80","author":"MJ Kim","year":"2011","unstructured":"M.J. Kim, A.H. Frankel, M. Donaldson, S.J. Darch, C.D. Pusey, P.D. Hill, M. Mayr, F.W.K. Tam, Oral cholecalciferol decreases albuminuria and urinary TGF-\u03b21 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int. 80, 851\u2013860 (2011)","journal-title":"Kidney Int."},{"key":"1369_CR64","doi-asserted-by":"crossref","first-page":"e50510","DOI":"10.1371\/journal.pone.0050510","volume":"7","author":"Y Huang","year":"2012","unstructured":"Y. Huang, H. Yu, J. Lu, K. Guo, L. Zhang, Y. Bao, H. Chen, W. Jia, Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy. PLoS One 7, e50510 (2012)","journal-title":"PLoS One"},{"key":"1369_CR65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ndt\/gft360","volume":"29","author":"P Molina","year":"2014","unstructured":"P. Molina, J.L. G\u00f3rriz, M.D. Molina, A. Peris, S. Beltr\u00e1n, J. Kanter, V. Escudero, R. Romero, L.M. Pallard\u00f3, The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrol. Dial. Transplant. 29, 97\u2013109 (2014)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR66","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2010.88","volume":"77","author":"O Garc\u00eda-S\u00e1nchez","year":"2010","unstructured":"O. Garc\u00eda-S\u00e1nchez, F.J. L\u00f3pez-Hern\u00e1ndez, J.M. L\u00f3pez-Novoa, An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int. 77, 950\u2013955 (2010)","journal-title":"Kidney Int."},{"key":"1369_CR67","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0175-3","volume":"74","author":"L Nicola De","year":"2014","unstructured":"L. De Nicola, F. Locatelli, G. Conte, R. Minutolo, Responsiveness to erythropoiesis-stimulating agents in chronic kidney disease: does geography matter? Drugs 74, 159\u2013168 (2014)","journal-title":"Drugs"},{"key":"1369_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"JA Kellum","year":"2012","unstructured":"J.A. Kellum, N. Lameire, P. Aspelin, R.S. Barsoum, E.A. Burdmann, S.L. Goldstein, C.A. Herzog, M. Joannidis, A. Kribben et al., KDIGO 2012. Kidney Int. 2, 1 (2012)","journal-title":"Kidney Int."},{"key":"1369_CR69","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1093\/ndt\/gfs007","volume":"27","author":"R Minutolo","year":"2012","unstructured":"R. Minutolo, G. Conte, B. Cianciaruso, V. Bellizzi, A. Camocardi, L. De Paola, L. De Nicola, Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients. Nephrol. Dial. Transplant. 27, 2880\u20132886 (2012)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2016.05.031","volume":"68","author":"J Luo","year":"2016","unstructured":"J. Luo, D.E. Jensen, B.J. Maroni, S.M. Brunelli, Spectrum and burden of erythropoiesis-stimulating agent hyporesponsiveness among contemporary hemodialysis patients. Am. J. Kidney Dis. 68, 763\u2013771 (2016)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR71","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ndt\/12.3.514","volume":"12","author":"S Albitar","year":"1997","unstructured":"S. Albitar, R. Genin, M. Fen-Chong, M.O. Serveaux, D. Schohn, C. Chuet, High-dose alfacalcidol improves anemia in patients on hemodialysis. Nephrol. Dial. Transplant. 12, 514\u2013518 (1997)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR72","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2009.551","volume":"77","author":"NM Patel","year":"2010","unstructured":"N.M. Patel, O.M. Guti\u00e9rrez, D.L. Andress, D.W. Coyne, A. Levin, M. Wolf, Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int. 77, 715\u2013720 (2010)","journal-title":"Kidney Int."},{"key":"1369_CR73","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/ndt\/gft021","volume":"28","author":"A Icardi","year":"2013","unstructured":"A. Icardi, E. Paoletti, L. De Nicola, S. Mazzaferro, R. Russo, M. Cozzolino, Renal anemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. Nephrol. Dial. Transplant. 28, 1672\u20131679 (2013)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR74","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/jcph.556","volume":"55","author":"B Afsar","year":"2015","unstructured":"B. Afsar, E. Agca, S. Turk, Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol. J. Clin. Pharmacol. 55, 1280\u20131285 (2015)","journal-title":"J. Clin. Pharmacol."},{"key":"1369_CR75","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2013040355","volume":"25","author":"J Bacchetta","year":"2014","unstructured":"J. Bacchetta, J.J. Zaritsky, J.L. Sea, R.F. Chun, T.S. Lisse, K. Zavala, A. Nayak, K. Wesseling-Perry, M. Westerman et al., Suppression of iron-regulatory hepcidin by vitamin D. J. Am. Soc. Nephrol. 25, 564\u2013572 (2014)","journal-title":"J. Am. Soc. Nephrol."},{"key":"1369_CR76","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1681\/ASN.2015040468","volume":"27","author":"DC Miskulin","year":"2016","unstructured":"D.C. Miskulin, K. Majchrzak, H. Tighiouart, R.S. Muther, T. Kapoian, D.S. Johnson, D.E. Weiner, Ergocalciferol supplementation in hemodialysis patients with vitamin d deficiency: a randomized clinical trial. J. Am. Soc. Nephrol. 27, 1801\u20131810 (2016)","journal-title":"J. Am. Soc. Nephrol."},{"key":"1369_CR77","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD), Kidney Int. Suppl. 76 (Suppl. 113), S1\u2013130 (2009)"},{"key":"1369_CR78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","volume":"25","author":"AYM Wang","year":"2014","unstructured":"A.Y.-M. Wang, F. Fang, J. Chan, Y.-Y. Wen, S. Qing, I.H.-S. Chan, G. Lo, K.-N. Lai, W.-K. Lo et al., Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial. J. Am. Soc. Nephrol. 25, 175\u2013186 (2014)","journal-title":"J. Am. Soc. Nephrol."},{"key":"1369_CR79","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"R. Thadhani, E. Appelbaum, Y. Pritchett, Y. Chang, J. Wenger, H. Tamez, I. Bhan, R. Agarwal, C. Zoccali et al., Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA 307, 674\u2013684 (2012)","journal-title":"JAMA"},{"key":"1369_CR80","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/nep.12505","volume":"20","author":"XH Li","year":"2015","unstructured":"X.-H.Li, L.Feng, Z.-H.Yang, Y.-H.Liao, The effect of active vitamin D on cardiovascular outcomes in predialysis chronic kidney diseases: a systematic review and meta-analysis. Nephrology 20, 706\u2013714 (2015)","journal-title":"Nephrology"},{"key":"1369_CR81","doi-asserted-by":"crossref","first-page":"e61387","DOI":"10.1371\/journal.pone.0061387","volume":"8","author":"L Xu","year":"2013","unstructured":"L. Xu, X. Wan, Z. Huang, F. Zeng, G. Wei, D. Fang, W. Deng, Y. Li, Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials. PLoS One 8, e61387 (2013)","journal-title":"PLoS One"},{"key":"1369_CR82","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.ajkd.2014.04.020","volume":"64","author":"A Massart","year":"2014","unstructured":"A. Massart, F.D. Debelle, J. Racap\u00e9, C. Gervy, C. Husson, M. Dhaene, K.M. Wissing, J.L. Nortier, Biochemical parameters after cholecalciferol repletion in hemodialysis: results from the VitaDial randomized trial. Am. J. Kidney Dis. 64, 696\u2013705 (2014)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR83","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2014.08.004","volume":"64","author":"V Tangpricha","year":"2014","unstructured":"V. Tangpricha, H. Wasse, Vitamin D therapy in kidney disease: more vitamin D is necessary. Am. J. Kidney Dis. 64, 667\u2013669 (2014)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/derm.20014","volume":"4","author":"J Alvarez","year":"2012","unstructured":"J. Alvarez, H. Wasse, V. Tangpricha, Vitamin D supplementation in pre-dialysis chronic kidney disease: a systematic review. Dermatoendocrinology 4, 118\u2013127 (2012)","journal-title":"Dermatoendocrinology"},{"key":"1369_CR85","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1525-139X.2010.00722.x","volume":"23","author":"G Jones","year":"2010","unstructured":"G. Jones, Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin. Dial. 23, 239\u2013243 (2010)","journal-title":"Semin. Dial."},{"key":"1369_CR86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11255-014-0842-7","volume":"47","author":"S Dusilov\u00e1-Sulkov\u00e1","year":"2015","unstructured":"S. Dusilov\u00e1-Sulkov\u00e1, R. \u0160afr\u00e1nek, J. V\u00e1vrov\u00e1, J. Hor\u00e1\u010dek, L. Pavl\u00edkov\u00e1, V. Pali\u010dka, Low-dose cholecalciferol supplementation and dual vitamin D therapy in hemodialysis patients. Int. Urol. Nephrol. 47, 169\u2013176 (2015)","journal-title":"Int. Urol. Nephrol."},{"key":"1369_CR87","first-page":"145828","volume":"2015","author":"D Santoro","year":"2015","unstructured":"D. Santoro, D. Caccamo, S. Lucisano, M. Buemi, K. Sebekova, D. Teta, L. De Nicola, Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system. BioMed Res. Int. 2015, 145828 (2015)","journal-title":"BioMed Res. Int."},{"key":"1369_CR88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Y.C. Li, J. Kong, M. Wei, Z.-F. Chen, S.Q. Liu, L.-P. Cao, 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110, 229\u2013238 (2002)","journal-title":"J. Clin. Invest."},{"key":"1369_CR89","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","volume":"288","author":"W Xiang","year":"2005","unstructured":"W. Xiang, J. Kong, S. Chen, L.-P. Cao, G. Qiao, W. Zheng, W. Liu, X. Li, D.G. Gardner et al., Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab. 288, E125\u2013132 (2005)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1369_CR90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI0216160","volume":"110","author":"CD Sigmund","year":"2002","unstructured":"C.D. Sigmund, Regulation of renin expression and blood pressure by vitamin D(3). J. Clin. Invest. 110, 155\u2013156 (2002)","journal-title":"J. Clin. Invest."},{"key":"1369_CR91","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.02260409","volume":"4","author":"JN Artaza","year":"2009","unstructured":"J.N. Artaza, R. Mehrotra, K.C. Norris, Vitamin D and the cardiovascular system. Clin.J. Am. Soc. Nephrol. 4, 1515\u20131522 (2009)","journal-title":"Clin.J. Am. Soc. Nephrol."},{"key":"1369_CR92","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ki.2009.288","volume":"76","author":"R Mehrotra","year":"2009","unstructured":"R. Mehrotra, D.A. Kermah, I.B. Salusky, M.S. Wolf, R.I. Thadhani, Y.-W. Chiu, D. Martins, S.G. Adler, K.C. Norris, Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 76, 977\u2013983 (2009)","journal-title":"Kidney Int."},{"key":"1369_CR93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","volume":"50","author":"IH Boer de","year":"2007","unstructured":"I.H. de Boer, G.N. Ioannou, B. Kestenbaum, J.D. Brunzell, N.S. Weiss, 25-hydroxyvitamin D levels and albuminuria in the third national health and nutrition examination survey (NHANES III). Am. J. Kidney Dis. 50, 69\u201377 (2007)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR94","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/HYPERTENSIONAHA.107.087288","volume":"49","author":"JP Forman","year":"2007","unstructured":"J.P. Forman, E. Giovannucci, M.D. Holmes, H.A. Bischoff-Ferrari, S.S. Tworoger, W.C. Willett, G.C. Curhan, Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 1063\u20131069 (2007)","journal-title":"Hypertension"},{"key":"1369_CR95","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.29.03.06.dc05-1961","volume":"29","author":"AG Pittas","year":"2006","unstructured":"A.G. Pittas, B. Dawson-Hughes, T. Li, R.M. Van Dam, W.C. Willett, J.E. Manson, F.B. Hu, Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650\u2013656 (2006)","journal-title":"Diabetes Care"},{"key":"1369_CR96","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","volume":"348","author":"E Theodoratou","year":"2014","unstructured":"E. Theodoratou, I. Tzoulaki, L. Zgaga, J.P.A. Ioannidis, Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyzes of observational studies and randomized trials. BMJ 348, g2035 (2014)","journal-title":"BMJ"},{"key":"1369_CR97","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","volume":"72","author":"M Wolf","year":"2007","unstructured":"M. Wolf, A. Shah, O. Gutierrez, E. Ankers, M. Monroy, H. Tamez, D. Steele, Y. Chang, C.A. Camargo et al.,. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 72, 1004\u20131013 (2007)","journal-title":"Kidney Int."},{"key":"1369_CR98","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0003319709351875","volume":"61","author":"KO Kilickesmez","year":"2010","unstructured":"K.O. Kilickesmez, O. Abaci, B. Okcun, C. Kocas, M. Baskurt, A. Arat, M. Ersanli, T. Gurmen, Chronic kidney disease as a predictor of coronary lesion morphology. Angiology 61, 344\u2013349 (2010)","journal-title":"Angiology"},{"key":"1369_CR99","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2215\/CJN.06420909","volume":"5","author":"RM Holden","year":"2010","unstructured":"R.M. Holden, A.R. Morton, J.S. Garland, A. Pavlov, A.G. Day, S.L. Booth, Vitamins K and D status in stages 3-5 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 590\u2013597 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1369_CR100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","volume":"54","author":"S Fishbane","year":"2009","unstructured":"S. Fishbane, H. Chittineni, M. Packman, P. Dutka, N. Ali, N. Durie, Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am. J. Kidney Dis. 54, 647\u2013652 (2009)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR101","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2215\/CJN.02010309","volume":"4","author":"R Agarwal","year":"2009","unstructured":"R. Agarwal, Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD, Clin. J. Am. Soc. Nephrol. 4, 1523\u20131528 (2009)","journal-title":"J. Am. Soc. Nephrol."},{"key":"1369_CR102","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjhyper.2007.01.017","volume":"20","author":"R Scragg","year":"2007","unstructured":"R. Scragg, M. Sowers, C. Bell, Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third national health and nutrition examination survey. Am. J. Hypertens. 20, 713\u2013719 (2007)","journal-title":"Am. J. Hypertens."},{"key":"1369_CR103","first-page":"1633","volume":"86","author":"M Pfeifer","year":"2001","unstructured":"M. Pfeifer, B. Begerow, H.W. Minne, D. Nachtigall, C. Hansen, Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab. 86, 1633\u20131637 (2001)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR104","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/HYPERTENSIONAHA.111.00659","volume":"61","author":"JP Forman","year":"2013","unstructured":"J.P. Forman, J.B. Scott, K. Ng, B.F. Drake, E.G. Suarez, D.L. Hayden, G.G. Bennett, P.D. Chandler, B.W. Hollis et al., Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61, 779\u2013785 (2013)","journal-title":"Hypertension"},{"key":"1369_CR105","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajh.2012.111","volume":"25","author":"T Larsen","year":"2012","unstructured":"T. Larsen, F.H. Mose, J.N. Bech, A.B. Hansen, E.B. Pedersen, Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am. J. Hypertens. 25, 1215\u20131222 (2012)","journal-title":"Am. J. Hypertens."},{"key":"1369_CR106","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(05)60827-6","volume":"352","author":"R Krause","year":"1998","unstructured":"R. Krause, M. B\u00fchring, W. Hopfenm\u00fcller, M.F. Holick, A.M. Sharma, Ultraviolet B and blood pressure. Lancet 352, 709\u2013710 (1998)","journal-title":"Lancet"},{"key":"1369_CR107","first-page":"CD007470","volume":"7","author":"G Bjelakovic","year":"2014","unstructured":"G. Bjelakovic, LL. Gluud, D. Nikolova, K. Whitfield, J. Wetterslev, RG. Simonetti, M. Bjelakovic, C. Gluud,Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 7, CD007470 (2014)","journal-title":"Cochrane Database Syst. Rev."},{"key":"1369_CR108","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","volume":"34","author":"J Bover","year":"2014","unstructured":"J. Bover, P. Ure\u00f1a, V. Brandenburg, D. Goldsmith, C. Ruiz, I. DaSilva, R.J. Bosch, Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin. Nephrol. 34, 626\u2013640 (2014)","journal-title":"Semin. Nephrol."},{"key":"1369_CR109","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.semnephrol.2014.09.004","volume":"34","author":"PU Torres","year":"2014","unstructured":"P.U. Torres, J. Bover, S. Mazzaferro, M.C. de Vernejoul, M. Cohen-Solal, When, how, and why a bone biopsy should be performed in patients with chronic kidney disease. Semin. Nephrol. 34, 612\u2013625 (2014)","journal-title":"Semin. Nephrol."},{"key":"1369_CR110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","volume":"26","author":"JB Cannata-And\u00eda","year":"2013","unstructured":"J.B. Cannata-And\u00eda, M. Rodriguez Garc\u00eda, C. G\u00f3mez Alonso, Osteoporosis and adynamic bone in chronic kidney disease. J. Nephrol. 26, 73\u201380 (2013)","journal-title":"J. Nephrol."},{"key":"1369_CR111","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.2406","volume":"30","author":"SL West","year":"2015","unstructured":"S.L. West, C.E. Lok, L. Langsetmo, A.M. Cheung, E. Szabo, D. Pearce, M. Fusaro, R. Wald, J. Weinstein et al., Bone mineral density predicts fractures in chronic kidney disease. J. Bone Miner. Res. 30, 913\u2013919 (2015)","journal-title":"J. Bone Miner. Res."},{"key":"1369_CR112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","volume":"89","author":"TB Dr\u00fceke","year":"2016","unstructured":"T.B. Dr\u00fceke, Z.A. Massy, Changing bone patterns with progression of chronic kidney disease. Kidney Int. 89, 289\u2013302 (2016)","journal-title":"Kidney Int."},{"key":"1369_CR113","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ndt\/gfw082","volume":"31","author":"DJA Goldsmith","year":"2016","unstructured":"D.J.A. Goldsmith, Pro: should we correct vitamin D deficiency\/insufficiency in chronic kidney disease patients with inactive forms of vitamin D or just treat them with active vitamin D forms? Nephrol. Dial. Transplant 31, 698\u2013705 (2016)","journal-title":"Nephrol. Dial. Transplant"},{"key":"1369_CR114","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gfw080","volume":"31","author":"R Agarwal","year":"2016","unstructured":"R. Agarwal, P.I. Georgianos, Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease. Nephrol. Dial. Transplant. 31, 706\u2013713 (2016)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR115","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ndt\/gfw081","volume":"31","author":"C Zoccali","year":"2016","unstructured":"C. Zoccali, F. Mallamaci, Moderator\u2019s view: vitamin D deficiency treatment in advanced chronic kidney disease: a close look at the emperor\u2019s clothes. Nephrol. Dial. Transplant. 31, 714\u2013716 (2016)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR116","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"H.H. Malluche, H.W. Mawad, M.-C. Monier-Faugere, Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J. Bone Miner. Res. 26, 1368\u20131376 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"1369_CR117","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"S.M. Sprague, E. Bellorin-Font, V. Jorgetti, A.B. Carvalho, H.H. Malluche, A. Ferreira, P.C. D\u2019Haese, T.B. Dr\u00fceke, H. Du et al., Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am. J. Kidney Dis. 67, 559\u2013566 (2016)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR118","first-page":"289","volume":"36","author":"FC Barreto","year":"2014","unstructured":"F.C. Barreto, D.V. Barreto, M.E.F. Canziani, C. Tomiyama, A. Higa, A. Mozar, G. Glorieux, R. Vanholder, Z. Massy et al., Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients. J. Bras. Nefrol 36, 289\u2013296 (2014)","journal-title":"J. Bras. Nefrol"},{"key":"1369_CR119","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","volume":"11","author":"G Coen","year":"1996","unstructured":"G. Coen, S. Mazzaferro, P. Ballanti, D. Sardella, S. Chicca, M. Manni, E. Bonucci, F. Taggi, Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol. Dial. Transplant. 11, 813\u2013819 (1996)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/sdi.12499","volume":"29","author":"RF Reilly","year":"2016","unstructured":"R.F. Reilly, We use too much vitamin D in hemodialysis patients. Semin. Dial. 29, 320\u2013322 (2016)","journal-title":"Semin. Dial."},{"key":"1369_CR121","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/1759720X15588521","volume":"7","author":"SB Tanner","year":"2015","unstructured":"S.B. Tanner, S.A. Harwell, More than healthy bones: a review of vitamin D in muscle health. Ther. Adv. Musculoskelet. Dis 7, 152\u2013159 (2015)","journal-title":"Ther. Adv. Musculoskelet. Dis"},{"key":"1369_CR122","first-page":"19","volume":"9","author":"G Coen","year":"1983","unstructured":"G. Coen, M. Taccone Gallucci, E. Bonucci, P. Ballanti, A.R. Bianchi, G. Bianchini, M.C. Matteucci, S. Mazzaferro, S. Picca et al., 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone. Miner. Electrolyte Metab. 9, 19\u201327 (1983)","journal-title":"Miner. Electrolyte Metab."},{"key":"1369_CR123","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","volume":"59","author":"C Aranow","year":"2011","unstructured":"C. Aranow, Vitamin D and the immune system. J. Investig. Med. 59, 881\u2013886 (2011)","journal-title":"J. Investig. Med."},{"key":"1369_CR124","first-page":"244","volume":"5","author":"TK W\u00f6bke","year":"2014","unstructured":"T.K. W\u00f6bke, B.L. Sorg, D. Steinhilber, Vitamin D in inflammatory diseases. Front. Physiol 5, 244 (2014)","journal-title":"Front. Physiol"},{"key":"1369_CR125","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1210\/jc.2013-2653","volume":"98","author":"BW Hollis","year":"2013","unstructured":"B.W. Hollis, C.L. Wagner, Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J. Clin. Endocrinol. Metab. 98, 4619\u20134628 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR126","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1210\/jcem-57-6-1308","volume":"57","author":"AK Bhalla","year":"1983","unstructured":"A.K. Bhalla, E.P. Amento, T.L. Clemens, M.F. Holick, S.M. Krane, Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57, 1308\u20131310 (1983)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR127","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","volume":"10","author":"F Baeke","year":"2010","unstructured":"F. Baeke, T. Takiishi, H. Korf, C. Gysemans, C. Mathieu, Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482\u2013496 (2010)","journal-title":"Curr. Opin. Pharmacol."},{"key":"1369_CR128","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1017\/S0029665110001722","volume":"69","author":"MT Cantorna","year":"2010","unstructured":"M.T. Cantorna, Mechanisms underlying the effect of vitamin D on the immune system. Proc. Nutr. Soc. 69, 286\u2013289 (2010)","journal-title":"Proc. Nutr. Soc."},{"key":"1369_CR129","first-page":"151","volume":"5","author":"RF Chun","year":"2014","unstructured":"R.F. Chun, P.T. Liu, R.L. Modlin, J.S. Adams, M. Hewison, Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front. Physiol. 5, 151 (2014)","journal-title":"Front. Physiol."},{"key":"1369_CR130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-015-0547-4","volume":"50","author":"T Skaaby","year":"2015","unstructured":"T. Skaaby, L.L.N. Husemoen, B.H. Thuesen, A. Linneberg, Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine 50, 231\u2013238 (2015)","journal-title":"Endocrine"},{"key":"1369_CR131","doi-asserted-by":"crossref","first-page":"R216","DOI":"10.1186\/ar3195","volume":"12","author":"M Rossini","year":"2010","unstructured":"M. Rossini, S. Maddali Bongi, G. La Montagna, G. Minisola, N. Malavolta, L. Bernini, E. Cacace, L. Sinigaglia, O. Di Munno et al., Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther. 12, R216 (2010)","journal-title":"Arthritis Res. Ther."},{"key":"1369_CR132","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4081\/reumatismo.2014.788","volume":"66","author":"M Rossini","year":"2014","unstructured":"M. Rossini, D. Gatti, O. Viapiana, C. Caimmi, L. Idolazzi, E. Fracassi, S. Adami, Vitamin D and rheumatic diseases. Reumatismo 66, 153\u2013170 (2014)","journal-title":"Reumatismo"},{"key":"1369_CR133","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0961203311427549","volume":"21","author":"J Bogaczewicz","year":"2012","unstructured":"J. Bogaczewicz, A. Sysa-Jedrzejowska, C. Arkuszewska, J. Zabek, E. Kontny, D. McCauliffe, A. Wozniacka, Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 21, 477\u2013484 (2012)","journal-title":"Lupus"},{"key":"1369_CR134","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0961203309360807","volume":"19","author":"E Cutillas-Marco","year":"2010","unstructured":"E. Cutillas-Marco, M. Morales-Su\u00e1rez-Varela, A. Marquina-Vila, W. Grant, Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 19, 810\u2013814 (2010)","journal-title":"Lupus"},{"key":"1369_CR135","first-page":"1291","volume":"30","author":"LH Damanhouri","year":"2009","unstructured":"L.H. Damanhouri, Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med. J. 30, 1291\u20131295 (2009)","journal-title":"Saudi Med. J."},{"key":"1369_CR136","doi-asserted-by":"crossref","first-page":"CR711","DOI":"10.12659\/MSM.882131","volume":"17","author":"RT Hamza","year":"2011","unstructured":"R.T. Hamza, K.S. Awwad, M.K. Ali, A.I. Hamed, Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med. Sci. Monit. 17, CR711\u2013CR718 (2011)","journal-title":"Med. Sci. Monit."},{"key":"1369_CR137","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2133.2010.09948.x","volume":"163","author":"G Heine","year":"2010","unstructured":"G. Heine, A. Lahl, C. M\u00fcller, M. Worm, Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year. Br. J. Dermatol. 163, 863\u2013865 (2010)","journal-title":"Br. J. Dermatol."},{"key":"1369_CR138","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00296-010-1442-1","volume":"31","author":"HA Kim","year":"2011","unstructured":"H.-A. Kim, J.-M. Sung, J.-Y. Jeon, J.-M. Yoon, C.-H. Suh, Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatol. Int. 31, 1189\u20131194 (2011)","journal-title":"Rheumatol. Int."},{"key":"1369_CR139","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/03009742.2012.697189","volume":"41","author":"J Mu\u00f1oz-Ortego","year":"2012","unstructured":"J. Mu\u00f1oz-Ortego, V. Torrente-Segarra, D. Prieto-Alhambra, T.C. Salman-Monte, J. Carbonell-Abello, Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study. Scand. J. Rheumatol. 41, 472\u2013475 (2012)","journal-title":"Scand. J. Rheumatol."},{"key":"1369_CR140","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/0961203311401457","volume":"20","author":"M Souto","year":"2011","unstructured":"M. Souto, A. Coelho, C. Guo, L. Mendon\u00e7a, S. Argolo, J. Papi, M. Farias, Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus 20, 1019\u20131026 (2011)","journal-title":"Lupus"},{"key":"1369_CR141","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/0961203311404915","volume":"20","author":"G Gilkeson","year":"2011","unstructured":"G. Gilkeson, J. James, D. Kamen, T. Knackstedt, D. Maggi, A. Meyer, N. Ruth, The United States to Africa lupus prevalence gradient revisited. Lupus 20, 1095\u20131103 (2011)","journal-title":"Lupus"},{"key":"1369_CR142","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s11033-010-0477-4","volume":"38","author":"YH Lee","year":"2011","unstructured":"Y.H. Lee, S.-C. Bae, S.J. Choi, J.D. Ji, G.G. Song, Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol. Biol. Rep. 38, 3643\u20133651 (2011)","journal-title":"Mol. Biol. Rep."},{"key":"1369_CR143","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0961203311422709","volume":"21","author":"XY Luo","year":"2012","unstructured":"X.-Y. Luo, M.-H. Yang, F.-X. Wu, L.-J. Wu, L. Chen, Z. Tang, N.-T. Liu, X.-F. Zeng, J.-L. Guan et al., Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21, 53\u201359 (2012)","journal-title":"Lupus"},{"key":"1369_CR144","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/ard.2010.148494","volume":"70","author":"LL Ritterhouse","year":"2011","unstructured":"L.L. Ritterhouse, S.R. Crowe, T.B. Niewold, D.L. Kamen, S.R. Macwana, V.C. Roberts, A.B. Dedeke, J.B. Harley, R.H. Scofield et al., Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 70, 1569\u20131574 (2011)","journal-title":"Ann. Rheum. Dis."},{"key":"1369_CR145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/03009742.2010.507220","volume":"40","author":"P Szodoray","year":"2011","unstructured":"P. Szodoray, T. Tarr, A. Bazso, G. Poor, G. Szegedi, E. Kiss, The immunopathological role of vitamin D in patients with SLE: data from a single center registry in Hungary. Scand. J. Rheumatol. 40, 122\u2013126 (2011)","journal-title":"Scand. J. Rheumatol."},{"key":"1369_CR146","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0961203311422094","volume":"21","author":"CC Mok","year":"2012","unstructured":"C.C. Mok, D.J. Birmingham, L.Y. Ho, L.A. Hebert, H. Song, B.H. Rovin, Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus 21, 36\u201342 (2012)","journal-title":"Lupus"},{"key":"1369_CR147","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/ker212","volume":"51","author":"CC Mok","year":"2012","unstructured":"C.C. Mok, D.J. Birmingham, H.W. Leung, L.A. Hebert, H. Song, B.H. Rovin, Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology 51, 644\u2013652 (2012)","journal-title":"Rheumatology"},{"key":"1369_CR148","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1756-185X.2011.01653.x","volume":"15","author":"SS Yeap","year":"2012","unstructured":"S.S. Yeap, A.Z. Othman, A.A. Zain, S.P. Chan, Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int. J. Rheum. Dis 15, 17\u201324 (2012)","journal-title":"Int. J. Rheum. Dis"},{"key":"1369_CR149","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0961203311405703","volume":"20","author":"ZS Bonakdar","year":"2011","unstructured":"Z.S. Bonakdar, L. Jahanshahifar, F. Jahanshahifar, A. Gholamrezaei, Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 20, 1155\u20131160 (2011)","journal-title":"Lupus"},{"key":"1369_CR150","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2009.120329","volume":"69","author":"H Amital","year":"2010","unstructured":"H. Amital, Z. Szekanecz, G. Sz\u00fccs, K. Dank\u00f3, E. Nagy, T. Cs\u00e9p\u00e1ny, E. Kiss, J. Rovensky, A. Tuchynova et al., Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann. Rheum. Dis. 69, 1155\u20131157 (2010)","journal-title":"Ann. Rheum. Dis."},{"key":"1369_CR151","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0961203309345775","volume":"19","author":"SMA Toloza","year":"2010","unstructured":"S.M.A. Toloza, D.E.C. Cole, D.D. Gladman, D. Iba\u00f1ez, M.B. Urowitz, Vitamin D insufficiency in a large female SLE cohort. Lupus 19, 13\u201319 (2010)","journal-title":"Lupus"},{"key":"1369_CR152","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpeds.2009.02.033","volume":"155","author":"TB Wright","year":"2009","unstructured":"T.B. Wright, J. Shults, M.B. Leonard, B.S. Zemel, J.M. Burnham, Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J. Pediatr. 155, 260\u2013265 (2009)","journal-title":"J. Pediatr."},{"key":"1369_CR153","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/0961203312454929","volume":"21","author":"CB Casella","year":"2012","unstructured":"C.B. Casella, L.P.C. Seguro, L. Takayama, D. Medeiros, E. Bonfa, R.M.R. Pereira, Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21, 1335\u20131342 (2012)","journal-title":"Lupus"},{"key":"1369_CR154","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpeds.2011.08.011","volume":"160","author":"AB Robinson","year":"2012","unstructured":"A.B. Robinson, M. Thierry-Palmer, K.L. Gibson, C.E. Rabinovich, Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. J. Pediatr. 160, 297\u2013302 (2012)","journal-title":"J. Pediatr."},{"key":"1369_CR155","doi-asserted-by":"crossref","first-page":"e9193","DOI":"10.1371\/journal.pone.0009193","volume":"5","author":"I Ben-Zvi","year":"2010","unstructured":"I. Ben-Zvi, C. Aranow, M. Mackay, A. Stanevsky, D.L. Kamen, L.M. Marinescu, C.E. Collins, G.S. Gilkeson, B. Diamond et al., The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 5, e9193 (2010)","journal-title":"PLoS One"},{"key":"1369_CR156","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar4479","volume":"16","author":"M Mandal","year":"2014","unstructured":"M. Mandal, R. Tripathy, A.K. Panda, S.S. Pattanaik, S. Dakua, A.K. Pradhan, S. Chakraborty, B. Ravindran, B.K. Das, Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha. Arthritis Res. Ther. 16, R49 (2014)","journal-title":"Arthritis Res. Ther."},{"key":"1369_CR157","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/0961203312439640","volume":"21","author":"DJ Birmingham","year":"2012","unstructured":"D.J. Birmingham, L.A. Hebert, H. Song, W.T. Noonan, B.H. Rovin, H.N. Nagaraja, C.Y. Yu, Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 21, 855\u2013864 (2012)","journal-title":"Lupus"},{"key":"1369_CR158","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10067-014-2530-5","volume":"33","author":"L Schneider","year":"2014","unstructured":"L. Schneider, A.S.P. Dos Santos, M. Santos, R.M. da Silva Chakr, O.A. Monticielo, Vitamin D and systemic lupus erythematosus: state of the art. Clin. Rheumatol. 33, 1033\u20131038 (2014)","journal-title":"Clin. Rheumatol."},{"key":"1369_CR159","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/art.37953","volume":"65","author":"M Petri","year":"2013","unstructured":"M. Petri, K.J. Bello, H. Fang, L.S. Magder, Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 65, 1865\u20131871 (2013)","journal-title":"Arthritis Rheum."},{"key":"1369_CR160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/jc.2014-3012","volume":"100","author":"CA Keyzer","year":"2015","unstructured":"C.A. Keyzer, I.J. Riphagen, M.M. Joosten, G. Navis, A.C. Muller Kobold, I.P. Kema, S.J.L. Bakker, M.H. de Borst; NIGRAM consortium, Associations of 25(OH) and 1,25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients. J. Clin. Endocrinol. Metab. 100, 81\u201389 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR161","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5500\/wjt.v2.i3.41","volume":"2","author":"WG Douthat","year":"2012","unstructured":"W.G. Douthat, C.R. Chiurchiu, P.U. Massari, New options for the management of hyperparathyroidism after renal transplantation. World J. Transplant. 2, 41\u201345 (2012)","journal-title":"World J. Transplant."},{"key":"1369_CR162","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00007890-199310000-00013","volume":"56","author":"RW Steiner","year":"1993","unstructured":"R.W. Steiner, M. Ziegler, N.A. Halasz, B.D. Catherwood, S. Manolagas, L.J. Deftos, Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation 56, 843\u2013846 (1993)","journal-title":"Transplantation"},{"key":"1369_CR163","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.TP.0000149322.70295.A5","volume":"79","author":"KM Wissing","year":"2005","unstructured":"K.M. Wissing, N. Broeders, R. Moreno-Reyes, C. Gervy, B. Stallenberg, D. Abramowicz, A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 79, 108\u2013115 (2005)","journal-title":"Transplantation"},{"key":"1369_CR164","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/1745-6215-15-430","volume":"15","author":"M Courbebaisse","year":"2014","unstructured":"M. Courbebaisse, C. Alberti, S. Colas, D. Pri\u00e9, J.-C. Souberbielle, J.-M. Treluyer, E. Thervet, VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial. Trials 15, 430 (2014)","journal-title":"Trials"},{"key":"1369_CR165","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/j.1600-6143.2007.01978.x","volume":"7","author":"A Stavroulopoulos","year":"2007","unstructured":"A. Stavroulopoulos, M.J.D. Cassidy, C.J. Porter, D.J. Hosking, S.D. Roe, Vitamin D status in renal transplant recipients. Am. J. Transplant. 7, 2546\u20132552 (2007)","journal-title":"Am. J. Transplant."},{"key":"1369_CR166","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000446863","volume":"43","author":"G Cianciolo","year":"2016","unstructured":"G. Cianciolo, A. Galassi, I. Capelli, M.L. Angelini, G. La Manna, M. Cozzolino, Vitamin D in kidney transplant recipients: mechanisms and therapy. Am. J. Nephrol. 43, 397\u2013407 (2016)","journal-title":"Am. J. Nephrol."},{"key":"1369_CR167","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/TP.0b013e31828eead8","volume":"95","author":"KL Naylor","year":"2013","unstructured":"K.L. Naylor, A.H. Li, N.N. Lam, A.B. Hodsman, S.A. Jamal, A.X. Garg, Fracture risk in kidney transplant recipients: a systematic review. Transplantation 95, 1461\u20131470 (2013)","journal-title":"Transplantation"},{"key":"1369_CR168","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/TP.0000000000000808","volume":"100","author":"KL Naylor","year":"2016","unstructured":"K.L. Naylor, S.A. Jamal, G. Zou, E. McArthur, N.N. Lam, W.D. Leslie, A.B. Hodsman, S.J. Kim, G.A. Knoll et al., Fracture incidence in adult kidney transplant recipients. Transplantation 100, 167\u2013175 (2016)","journal-title":"Transplantation"},{"key":"1369_CR169","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1359\/jbmr.091025","volume":"25","author":"S Giannini","year":"2010","unstructured":"S. Giannini, S. Sella, F. Silva Netto, C. Cattelan, L. Dalle Carbonare, R. Lazzarin, F. Marchini, P. Rigotti, C. Marcocci et al., Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency. J. Bone Miner. Res. 25, 841\u2013848 (2010)","journal-title":"J. Bone Miner. Res."},{"key":"1369_CR170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.ajkd.2012.07.022","volume":"61","author":"HM Alshayeb","year":"2013","unstructured":"H.M. Alshayeb, M.A. Josephson, S.M. Sprague, CKD-mineral and bone disorder management in kidney transplant recipients. Am. J. Kidney Dis. 61, 310\u2013325 (2013)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR171","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","volume":"288","author":"AM Ball","year":"2002","unstructured":"A.M. Ball, D.L. Gillen, D. Sherrard, N.S. Weiss, S.S. Emerson, S.L. Seliger, B.R. Kestenbaum, C. Stehman-Breen, Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288, 3014\u20133018 (2002)","journal-title":"JAMA"},{"key":"1369_CR172","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1047-2797(01)00226-5","volume":"11","author":"KC Abbott","year":"2001","unstructured":"K.C. Abbott, R.J. Oglesby, I.O. Hypolite, A.D. Kirk, C.W. Ko, P.G. Welch, L.Y. Agodoa, W.E. Duncan, Hospitalizations for fractures after renal transplantation in the United States. Ann. Epidemiol. 11, 450\u2013457 (2001)","journal-title":"Ann. Epidemiol."},{"key":"1369_CR173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650110102","volume":"11","author":"S Epstein","year":"1996","unstructured":"S. Epstein, Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J. Bone Miner. Res. 11, 1\u20137 (1996)","journal-title":"J. Bone Miner. Res."},{"key":"1369_CR174","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1359\/jbmr.2002.17.10.1768","volume":"17","author":"S Giannini","year":"2002","unstructured":"S. Giannini, A. D\u2019Angelo, M. Nobile, G. Carraro, P. Rigotti, F. Silva-Netto, S. Pavan, F. Marchini, M. Zaninotto et al., The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation. J. Bone Miner. Res. 17, 1768\u20131773 (2002)","journal-title":"J. Bone Miner. Res."},{"key":"1369_CR175","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0272-6386(97)90129-3","volume":"29","author":"G Dumoulin","year":"1997","unstructured":"G. Dumoulin, B. Hory, N.U. Nguyen, C. Bresson, V. Fournier, M. Bouhaddi, J.M. Chalopin, Y. Saint-Hillier, J. Regnard, No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients. Am. J. Kidney Dis. 29, 746\u2013753 (1997)","journal-title":"Am. J. Kidney Dis."},{"key":"1369_CR176","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1523-1755.1998.00142.x","volume":"54","author":"P Messa","year":"1998","unstructured":"P. Messa, C. Sindici, G. Cannella, V. Miotti, A. Risaliti, M. Gropuzzo, P.L. Di Loreto, F. Bresadola, G. Mioni, Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int. 54, 1704\u20131713 (1998)","journal-title":"Kidney Int."},{"key":"1369_CR177","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/TP.0000000000000823","volume":"100","author":"M Wolf","year":"2016","unstructured":"M. Wolf, M.R. Weir, N. Kopyt, R.B. Mannon, J. Von Visger, H. Deng, S. Yue, F. Vincenti, A prospective cohort study of mineral metabolism after kidney transplantation. Transplantation 100, 184\u2013193 (2016)","journal-title":"Transplantation"},{"key":"1369_CR178","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1399-0012.2003.00047.x","volume":"17","author":"J Heaf","year":"2003","unstructured":"J. Heaf, E. Tvedegaard, I.-L. Kanstrup, N. Fogh-Andersen, Hyperparathyroidism and long-term bone loss after renal transplantation. Clin. Transplant. 17, 268\u2013274 (2003)","journal-title":"Clin. Transplant."},{"key":"1369_CR179","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","volume":"13","author":"P Perrin","year":"2013","unstructured":"P. Perrin, S. Caillard, R.M. Javier, L. Braun, F. Heibel, C. Borni-Duval, C. Muller, J. Olagne, B. Moulin, Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am. J. Transplant. 13, 2653\u20132663 (2013)","journal-title":"Am. J. Transplant."},{"key":"1369_CR180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","volume":"33","author":"P Evenepoel","year":"2013","unstructured":"P. Evenepoel, Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin. Nephrol. 33, 191\u2013203 (2013)","journal-title":"Semin. Nephrol."},{"key":"1369_CR181","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1523-1755.2004.00986.x","volume":"66","author":"YFC Smets","year":"2004","unstructured":"Y.F.C. Smets, J.W. de Fijter, J. Ringers, H.H.P.J. Lemkes, N.A.T. Hamdy, Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation. Kidney Int. 66, 2070\u20132076 (2004)","journal-title":"Kidney Int."},{"key":"1369_CR182","doi-asserted-by":"crossref","unstructured":"P. Perrin, C. Kiener, R.-M. Javier, L. Braun, N. Cognard, G. Gautier-Vargas, F. Heibel, C. Muller, J. Olagne et al., Recent changes in chronic kidney disease-mineral and bone disorders (CKD-MBD) and associated fractures after kidney transplantation. Transplantation (2016) (from PubMed: Transplantation. 2016 Aug 19. [Epub ahead of print])","DOI":"10.1097\/TP.0000000000001449"},{"key":"1369_CR183","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","volume":"26","author":"M Trillini","year":"2015","unstructured":"M. Trillini, M. Cortinovis, P. Ruggenenti, J. Reyes Loaeza, K. Courville, C. Ferrer-Siles, S. Prandini, F. Gaspari, A. Cannata et al., Paricalcitol for secondary hyperparathyroidism in renal transplantation. J. Am. Soc. Nephrol. JASN 26, 1205\u20131214 (2015)","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"1369_CR184","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2015060622","volume":"27","author":"JM Cruzado","year":"2016","unstructured":"J.M. Cruzado, P. Moreno, J.V. Torregrosa, O. Taco, R. Mast, C. G\u00f3mez-Vaquero, C. Polo, I. Revuelta, J. Francos et al., A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J. Am. Soc. Nephrol. 27, 2487\u20132494 (2016)","journal-title":"J. Am. Soc. Nephrol."},{"key":"1369_CR185","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1016\/j.transproceed.2010.06.027","volume":"42","author":"ME Cho","year":"2010","unstructured":"M.E. Cho, Z. Duan, C.E. Chamberlain, J.C. Reynolds, M.S. Ring, R.B. Mannon, Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism. Transplant. Proc. 42, 3554\u20133558 (2010)","journal-title":"Transplant. Proc."},{"key":"1369_CR186","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1093\/ndt\/gfl201","volume":"21","author":"NC Boudville","year":"2006","unstructured":"N.C. Boudville, A.B. Hodsman, Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol. Dial. Transplant. 21, 2621\u20132624 (2006)","journal-title":"Nephrol. Dial. Transplant."},{"key":"1369_CR187","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1210\/jc.2005-0547","volume":"91","author":"K Querings","year":"2006","unstructured":"K. Querings, M. Girndt, J. Geisel, T. Georg, W. Tilgen, J. Reichrath, 25-hydroxyvitamin D deficiency in renal transplant recipients. J. Clin. Endocrinol. Metab. 91, 526\u2013529 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1369_CR188","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1399-0012.2007.00696.x","volume":"21","author":"DM Sadlier","year":"2007","unstructured":"D.M. Sadlier, C.C. Magee, Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study. Clin. Transplant. 21, 683\u2013688 (2007)","journal-title":"Clin. Transplant."},{"key":"1369_CR189","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ajcn\/87.2.431","volume":"87","author":"B Ewers","year":"2008","unstructured":"B. Ewers, A. Gasbjerg, C. Moelgaard, A.M. Frederiksen, P. Marckmann, Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am. J. Clin. Nutr. 87, 431\u2013437 (2008)","journal-title":"Am. J. Clin. Nutr."},{"key":"1369_CR190","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","volume":"348","author":"S Euvrard","year":"2003","unstructured":"S. Euvrard, J. Kanitakis, A. Claudy, Skin cancers after organ transplantation. N. Engl. J. Med. 348, 1681\u20131691 (2003)","journal-title":"N. Engl. J. Med."},{"key":"1369_CR191","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1684\/ejd.2015.2524","volume":"25","author":"SMH Rizvi","year":"2015","unstructured":"S.M.H. Rizvi, M.B. Veier\u00f8d, P.M. Thorsby, P. Helsing, Vitamin D in Norwegian renal transplant recipients: A longitudinal study with repeated measurements in winter and summer. Eur. J. Dermatol. 25, 234\u2013239 (2015)","journal-title":"Eur. J. Dermatol."},{"key":"1369_CR192","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1745-6215-10-36","volume":"10","author":"U Thiem","year":"2009","unstructured":"U. Thiem, G. Heinze, R. Segel, T. Perkmann, F. Kainberger, F. M\u00fchlbacher, W. H\u00f6rl, K. Borchhardt, VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome. Trials 10, 36 (2009)","journal-title":"Trials"},{"key":"1369_CR193","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/TP.0b013e3181613fb5","volume":"85","author":"SS Tripathi","year":"2008","unstructured":"S.S. Tripathi, E.M. Gibney, T.W.B. Gehr, A.L. King, M.J. Beckman, High prevalence of vitamin D deficiency in African American kidney transplant recipients. Transplantation 85, 767\u2013770 (2008)","journal-title":"Transplantation"},{"key":"1369_CR194","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/08860220802406369","volume":"30","author":"G Sahin","year":"2008","unstructured":"G. Sahin, N.S. Yasar, B. Sirmagul, C. Bal, A.U. Yalcin, The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study. Ren. Fail. 30, 992\u2013999 (2008)","journal-title":"Ren. Fail."},{"key":"1369_CR195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ki.2008.549","volume":"75","author":"M Courbebaisse","year":"2009","unstructured":"M. Courbebaisse, E. Thervet, J.C. Souberbielle, J. Zuber, D. Eladari, F. Martinez, M.-F. Mamzer-Bruneel, P. Urena, C. Legendre et al., Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 75, 646\u2013651 (2009)","journal-title":"Kidney Int."},{"key":"1369_CR196","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40620-015-0237-6","volume":"29","author":"X Barros","year":"2016","unstructured":"X. Barros, N.Y. Rodr\u00edguez, D. Fuster, L. Rodas, N. Esforzado, A. Mazza, D. Rubello, F. Campos, A. Tapias et al., Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients. J. Nephrol. 29, 703\u2013709 (2016)","journal-title":"J. Nephrol."},{"key":"1369_CR197","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2013-2421","volume":"99","author":"Y Obi","year":"2014","unstructured":"Y. Obi, T. Hamano, N. Ichimaru, K. Tomida, I. Matsui, N. Fujii, M. Okumi, J. Kaimori, K. Yazawa et al., Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study. J. Clin. Endocrinol. Metab. 99, 527\u2013535 (2014)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1369-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1369-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1369-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T16:27:35Z","timestamp":1719332855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1369-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":197,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1369-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}